A detailed history of Private Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Private Wealth Partners, LLC holds 4,460 shares of LLY stock, worth $3.91 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
4,460
Previous 3,880 14.95%
Holding current value
$3.91 Million
Previous $3.02 Million 33.76%
% of portfolio
0.3%
Previous 0.24%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $420,424 - $527,243
580 Added 14.95%
4,460 $4.04 Million
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $503,370 - $673,438
-850 Reduced 17.97%
3,880 $3.02 Million
Q4 2023

Feb 02, 2024

BUY
$525.19 - $619.13 $601,342 - $708,903
1,145 Added 31.94%
4,730 $2.76 Million
Q3 2023

Nov 06, 2023

BUY
$434.7 - $599.3 $495,558 - $683,202
1,140 Added 46.63%
3,585 $1.93 Million
Q2 2023

Aug 03, 2023

SELL
$350.74 - $468.98 $4,208 - $5,627
-12 Reduced 0.49%
2,445 $1.15 Million
Q1 2023

May 03, 2023

BUY
$310.63 - $364.82 $763,217 - $896,362
2,457 New
2,457 $843,000
Q1 2021

May 04, 2021

SELL
$164.32 - $212.72 $257,818 - $333,757
-1,569 Closed
0 $0
Q4 2020

Feb 03, 2021

SELL
$130.46 - $172.63 $65,230 - $86,315
-500 Reduced 24.17%
1,569 $265,000
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $220,948 - $240,335
2,069 New
2,069 $231,000
Q2 2019

Aug 06, 2019

SELL
$110.79 - $129.32 $193,882 - $226,310
-1,750 Closed
0 $0
Q1 2019

May 02, 2019

SELL
$111.31 - $131.02 $100,179 - $117,918
-900 Reduced 33.96%
1,750 $227,000
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $9,848 - $11,033
-93 Reduced 3.39%
2,650 $307,000
Q3 2018

Oct 25, 2018

BUY
$85.86 - $107.31 $7,984 - $9,979
93 Added 3.51%
2,743 $294,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $207,787 - $245,279
-2,800 Reduced 51.38%
2,650 $205,000
Q3 2017

Nov 06, 2017

BUY
$77.07 - $85.54 $420,031 - $466,193
5,450
5,450 $466,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Private Wealth Partners, LLC Portfolio

Follow Private Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Wealth Partners, LLC with notifications on news.